International Society of Hypertension

Lipid Lowering in the Hypertensive Patient

(A report by Peter Sever from the June 2017 issue of ISH Hypertension News)

Hypertension and dyslipidaemia frequently co-exist. It is not surprising, therefore, that the majority of hypertensive patients warrant consideration for concomitant lipid-lowering therapy.

The most recent meta-analyses published by the Cholesterol Treatment Trialists Collaboration, reported that the lowering of LDL-cholesterol by approximately 1mmol/L, was associated with a reduction in vascular events of about one quarter.1 This meta-analysis demonstrated that in virtually all subgroups of patients studied, the relative risk reductions were consistent, including patients with hypertension.


Click here for the full report by Peter Sever (ICCH, Imperial College, London, UK)


To view the June 2017 issue of ISH Hypertension News, click here.


ISH Hypertension News is available online @, ISSN: 2520-2782

Latest Tweets:

The ISH is positively committed to opposing discrimination against people on the grounds of gender, race, colour, nationality, religion, marital status, sexual orientation, class, age, disability, having dependants, HIV status or perceived lifestyle.